Case Report
Published on 20 Jan 2023
Case report: Posterior reversible encephalopathy syndrome, an adverse effect of lenvatinib and pembrolizumab combination therapy, in a patient with advanced endometrial cancer
in Gynecological Oncology
- 3,826 views
- 6 citations